✦ LIBER ✦

A phase I dose-escalation and pharmacokinetic study of enzastaurin and erlotinib in patients with advanced solid tumors

✍ Scribed by Sukhmani K. Padda; Yelena Krupitskaya; Laveena Chhatwani; George A. Fisher; Alexander D. Colevas; Melanie San Pedro-Salcedo; Rodney Decker; Jane E. Latz; Heather A. Wakelee

Book ID: 113028028
Publisher: Springer
Year: 2011
Tongue: English
Weight: 281 KB
Volume: 69
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-011-1792-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I dose escalation and pharmacokine

Phase I dose escalation and pharmacokinetic study of oral enzastaurin (LY317615) in advanced solid tumors

✍ Toru Mukohara; Shunji Nagai; Minori Koshiji; Kenichi Yoshizawa; Hironobu Minami 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 320 KB

Phase I Dose-Escalation and Pharmacokine

Phase I Dose-Escalation and Pharmacokinetic Study of Dasatinib in Patients with Advanced Solid Tumors

✍ Demetri, G. D.; Lo Russo, P.; MacPherson, I. R.J.; Wang, D.; Morgan, J. A.; Brun 📂 Article 📅 2009 🏛 American Association for Cancer Research 🌐 English ⚖ 238 KB

421 POSTER Phase I dose escalation and p

421 POSTER Phase I dose escalation and pharmacokinetic study of oral enzastaurin in Japanese patients with advanced solid tumour

✍ T. Mukohara; S. Nagai; Y. Nambu; K. Yoshizawa; H. Minami 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Phase I dose escalation study of docetax

Phase I dose escalation study of docetaxel with filgrastim support in patients with advanced solid tumors

✍ Gregory A. Masters; Bruce E. Brockstein; Sridhar Mani; Mark J. Ratain 📂 Article 📅 2003 🏛 Springer US 🌐 English ⚖ 69 KB

Sunitinib in combination with docetaxel

Sunitinib in combination with docetaxel in patients with advanced solid tumors: a phase I dose-escalation study

✍ Francisco Robert; Alan Sandler; Joan H. Schiller; Glenn Liu; Karen Harper; Lev V 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 233 KB

Phase I study of cetuximab, erlotinib, a

Phase I study of cetuximab, erlotinib, and bevacizumab in patients with advanced solid tumors

✍ Chia-Chi Lin; Emiliano Calvo; Kyriakos P. Papadopoulos; Amita Patnaik; John Sara 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 278 KB